secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXAGEN INC. (XGN)
CIK:        0001274737
Form:       8-K
Filed at:   2026-03-10T23:59:59+00:00
Accession:  0001274737-26-000007
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Exagen reports record FY 2025 revenue of $66.6M, up 20% YoY; guides FY 2026 revenue $70-73M
--------------------------------------------------------------------------------

- Full-year 2025 revenue $66.6M (+20% YoY); Q4 2025 revenue $16.6M.
- Full-year net loss $19.95M; adjusted EBITDA loss $9.79M; gross margin 58.3%.
- AVISE CTD test volume grew >11% YoY; trailing 12-month ASP rose to $441 (+7%).
- FY 2026 revenue guidance of $70M to $73M; path to cash flow positivity.
- Year-end cash $32.4M; strengthened by $20M equity offering and $25M credit facility.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1274737/000127473726000007/0001274737-26-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1274737/000127473726000007/exdx-20260310.htm
  HTML page:      https://secwatch.observer/filing/0001274737-26-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer